Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

TESARO Announces Participation in Two Investor Conferences

Posted on: 22 Nov 17

WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:

  • The Bank of America Merrill Lynch 2018 Healthcare Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 15, 2018. Tim Pearson, EVP and CFO of TESARO, will participate in an analyst-led moderated Q&A at 4:20 PM PT and in meetings with investors.
  • The Leerink Boston Biopharma Bus Tour on Thursday, May 17, 2018. Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at 1:00 PM ET and will answer questions from investors.

A live webcast of the presentation at the Bank of America conference will be available by visiting the Investors section of the TESARO website at An archived replay of this webcast will be available on the Company’s website for 14 days following the conferences.

TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by acquiring, developing and commercializing safer and more effective therapeutics. For more information, visit, and follow us on Twitter and LinkedIn.

For additional information, please contact:    
Jennifer Davis
Vice President, Corporate Communications and Investor Relations
+1.781.325.1116 or

Kate Rausch
Associate Director, Investor Relations
1.781-257-2505 or


Last updated on: 02/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.